133 related articles for article (PubMed ID: 4363967)
1. High performance liquid chromatography of ceramides: application to analysis in human tissues and demonstration of ceramide excess in Farber's disease.
Sugita M; Iwamori M; Evans J; McCluer RH; Dulaney JT; Moser HW
J Lipid Res; 1974 May; 15(3):223-6. PubMed ID: 4363967
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid composition of free ceramides of kidney and cerebellum from a patient with Farber's disease.
Sugita M; Connolly P; Dulaney JT; Moser HW
Lipids; 1973 Jul; 8(7):401-6. PubMed ID: 4740649
[No Abstract] [Full Text] [Related]
3. Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase.
Sugita M; Willians M; Dulaney JT; Moser HW
Biochim Biophys Acta; 1975 Jul; 398(1):125-31. PubMed ID: 238641
[TBL] [Abstract][Full Text] [Related]
4. Farber's disease as a ceramidosis: clinical, radiological and biochemical aspects.
Toppet M; Vamos-Hurwitz E; Jonniaux G; Cremer N; Tondeur M; Pelc S
Acta Paediatr Scand; 1978 Jan; 67(1):113-9. PubMed ID: 626064
[TBL] [Abstract][Full Text] [Related]
5. Above-normal urinary excretion of urinary ceramides in Farber's disease, and characterization of their components by high-performance liquid chromatography.
Iwamori M; Moser HW
Clin Chem; 1975 May; 21(6):725-9. PubMed ID: 1122616
[TBL] [Abstract][Full Text] [Related]
6. Ceramides in a patient with lipogranulomatosis (Farber's disease) with chronic course.
Samuelsson K; Zetterström R
Scand J Clin Lab Invest; 1971 Jun; 27(4):393-405. PubMed ID: 5109101
[No Abstract] [Full Text] [Related]
7. [Farber's disease (disseminated lipogranulomatosis) (author's transl)].
Schönenberg H; Lindenfelser R
Monatsschr Kinderheilkd (1902); 1974 Apr; 122(4):153-9. PubMed ID: 4832028
[No Abstract] [Full Text] [Related]
8. Analysis and quantitation of free ceramide containing nonhydroxy and 2-hydroxy fatty acids, and phytosphingosine by high-performance liquid chromatography.
Iwamori M; Costello C; Moser HW
J Lipid Res; 1979 Jan; 20(1):86-96. PubMed ID: 438657
[TBL] [Abstract][Full Text] [Related]
9. [Farber's disease. Anatomoclinical and ultrastructural study].
Dustin P; Tondeur M; Jonniaux G; Vamos-Hurwitz E; Pelc S
Bull Acad R Med Belg; 1974 Oct; 13(9):733-62. PubMed ID: 4479365
[No Abstract] [Full Text] [Related]
10. The cellular lesions of Farber's disease and their experimental reproduction in tissue culture.
Rutsaert J; Tondeur M; Vamos-Hurwitz E; Dustin P
Lab Invest; 1977 May; 36(5):474-80. PubMed ID: 194109
[TBL] [Abstract][Full Text] [Related]
11. Ceramidase deficiency in Farber's disease (lipogranulomatosis).
Sugita M; Dulaney JT; Moser HW
Science; 1972 Dec; 178(4065):1100-2. PubMed ID: 4678225
[TBL] [Abstract][Full Text] [Related]
12. Farber's lipogranulomatosis. Report of a case and demonstration of an excess of free ceramide and ganglioside.
Moser HW; Prensky AL; Wolfe HJ; Rosman NP
Am J Med; 1969 Dec; 47(6):869-90. PubMed ID: 5395479
[No Abstract] [Full Text] [Related]
13. Familial lipogranulomatosis (Farber's disease).
Amirhakimi GH; Haghighi P; Ghalambor MA; Honari S
Clin Genet; 1976 Jun; 9(6):625-30. PubMed ID: 1277575
[No Abstract] [Full Text] [Related]
14. The biochemical defect in Farber's disease.
Dulaney J; Moser HW; Sidbury J; Milunsky A
Adv Exp Med Biol; 1976; 68():403-11. PubMed ID: 937114
[No Abstract] [Full Text] [Related]
15. [Ultrastructural aspects of peripheral nerve lesions in one case of Farber's disease].
Vital C; Battin J; Rivel J; Hehunstre JP
Rev Neurol (Paris); 1976 Jun; 132(6):419-23. PubMed ID: 181809
[TBL] [Abstract][Full Text] [Related]
16. Chemical studies of Farber's disease.
Clausen J; Rampini S
Acta Neurol Scand; 1970; 46(3):313-22. PubMed ID: 5535909
[No Abstract] [Full Text] [Related]
17. [Indicative radiologic features in disseminated lipogranulomatosis (Farber's disease)].
Dihlmann W
Fortschr Geb Rontgenstr Nuklearmed; 1972 Jul; 117(1):47-51. PubMed ID: 4341608
[No Abstract] [Full Text] [Related]
18. Abnormalities of lysosomes in human diploid fibroblasts from patients with Farber's disease.
Chen WW; Decker GL
Biochim Biophys Acta; 1982 Oct; 718(2):185-92. PubMed ID: 6814495
[TBL] [Abstract][Full Text] [Related]
19. 3-Ketosphingolipids: application to the determination of sphingolipids which contain 4-sphingenine.
Iwamori M; Moser HW; McCluer RH; Kishimoto Y
Biochim Biophys Acta; 1975 Feb; 380(2):308-19. PubMed ID: 1120148
[TBL] [Abstract][Full Text] [Related]
20. Farber's disease (disseminated lipogranulomatosis)--a pathological, histochemical and ultrastructural study--.
Tanaka T; Takahashi K; Hakozaki H; Kimoto H; Suzuki Y
Acta Pathol Jpn; 1979 Jan; 29(1):135-55. PubMed ID: 219658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
